ICLR Prakiraan volume dodolan ICON Plc

Logo grafis ICON Corp (ICLR)

The stable humanitarian status of medicine minimizes external risks for ICON Public (ICLR). The company's future sales figures demonstrate positive dynamics, with the indicator holding at 15.95. Growth is driven by a unique patient base with rare pathologies. Effective integration of acquired assets by management allows the issuer to systematically outperform market revenue forecasts.

ICLR - Volume dodolan mangsa ngarep perusahaan iconplc.com ing rentang 04.07.2022 - 14.11.2026

ICON Public Limited Company (ICLR) - rincian metrik lan laporan keuangan

- nilai saham lan prakiraan konsensus rega:
Bagan rega ICON|ICLR - Target median analis
- data kapitalisasi pasar:
Kapitalisasi pasar ICON Public Limited Company|ICLR - Rega Tumbas Perusahaan
- informasi kapitalisasi buku:
Nilai Buku saben Saham ICON|ICLR - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku iconplc.com|ICLR - Aset Perusahaan
- rincian utang lan likuiditas:
Utang marang Ekuitas ICON Public|ICLR - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas ICON Plc|ICLR - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku ICON Public Limited Company|ICLR - Kewajiban jangka dawa|Kewajiban jangka cendhak perusahaan ICON|Rasio cepet iconplc.com
- statistik bathi lan rasio pasar:
ICLR - Bathi resik perusahaan|Bathi sing dikarepake ICON Public|ICLR - Rasio rega marang bathi|Pangali Forward P/E iconplc.com|ICLR - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA ICON Public Limited Company|ICLR - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) ICON|ICLR - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan iconplc.com|ICLR - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ICON Public
- data total pendapatan lan volume dodolan:
ICLR - Pendapatan perusahaan|Prakiraan pendapatan perusahaan ICON Public Limited Company|ICLR - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang prakiraan pendapatan ICON Public Limited Company
Pambiji fundamental:ICLR ICON Public
Produk mawa merek ICON Corp

ICON Public (ICLR) maintains an impeccable status as a leading CRO in clinical research, which is reflected in the dynamics of the company's projected sales volume—a key indicator of market confidence among pharmaceutical behemoths. This metric transforms static reporting into a continuous data stream, eliminating time lags and allowing investors to assess the asset's fundamental value through the lens of real-time operational activity.

Analisis pesaing ICON Public

Prakiraan pendapatan perusahaan IQVIA Holdings Inc. (IQV)|Dodolan mangsa ngarep perusahaan labcorp.com|Prakiraan volume dodolan MEDP (Medpace)|Dodolan mangsa ngarep perusahaan Charles River Laboratories International, Inc. (CRL)|Evotec Corp - Prakiraan volume dodolan|Fortrea Clinical (FTRE) - Volume dodolan mangsa ngarep perusahaan|lifecore.com (LFCR) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan omniab.com (OABI)|Prakiraan pendapatan perusahaan Inotiv|Prakiraan pendapatan perusahaan CDMO (Avid Bioservices Inc.)|Volume dodolan mangsa ngarep perusahaan CTLT (Catalent Pharma Solutions)|SCPX (Scorpius Holdings, Inc) - Pendapatan mangsa ngarep perusahaan